Examples of using Spiromax in English and their translations into German
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Keep your Spiromax dry and clean.
Preparing your new BiResp Spiromax.
BiResp Spiromax is NOT indicated for use in children 12 years of age and younger or adolescents 13 to 17 years of age.
Preparing your new DuoResp Spiromax.
If you use more BiResp Spiromax than you should, contact your doctor, pharmacist or nurse for advice.
People also translate
If you stop using BiResp Spiromax.
If you get pregnant while using BiResp Spiromax, do NOT stop using BiResp Spiromax but talk to your doctor immediately.
If you stop using Aerivio Spiromax.
The safety and efficacy of BiResp Spiromax in children, 12 years and younger and adolescents, 13 to 17 years of age has not yet been established.
If you stop using DuoResp Spiromax.
The higher strength, BiResp Spiromax 320/9 microgram(320 micrograms of budesonide and 9 micrograms of formoterol), can only be used for the regular treatment of asthma and for the treatment of COPD.
Tell your doctor if you are taking the following medicines, before starting to use Aerivio Spiromax.
It is also important to advise patients notto shake the inhaler before use and not to breathe out through the Spiromax and not to block the air vents when they are preparing the“Breathe” step.
Breathing difficulties or wheezing that gets worse straight after taking Aerivio Spiromax.
Studies were carried out to show that Vylaer Spiromax is bioequivalent to the reference medicine(i.e. produces the same level of the active substance in the body) and that the two medicines act in the same way.
Based on this plan, safety information has been included in the summary of product characteristics andthe package leaflet for BiResp Spiromax, including the appropriate precautions to be followed by healthcare professionals and patients.
Patek Philippe Spiromax® patented balance spring, Pulsomax® patented escapement and balance wheel GyromaxSi® patent on Oscillomax® sub- brand portfolio overall application seventeen patents and patent applications made in separate parts箇中.
The Agency's Committee for Medicinal Products for Human Use(CHMP)concluded that Airexar Spiromax has been shown to have comparable quality and to be bioequivalent to Seretide Diskus.
DuoResp Spiromax is not an appropriate treatment for the adult patient with only mild asthma who is not adequately controlled with an inhaled corticosteroid and“as needed” inhaled short-acting β2 adrenoreceptor agonists.
Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Aerivio Spiromax have been included in the summary of product characteristics and the package leaflet.
In addition, if you suddenly stop taking Aerivio Spiromax or reduce your dose of Aerivio Spiromax this may(very rarely) cause you to have problems with your adrenal glands(adrenal insufficiency) which sometimes causes side effects.
The data from the study indicated that regardless of age and underlying disease severity, children, adolescents and adults with asthma as well as patients with COPD wereable to achieve inspiratory flow rates through the Spiromax device that were similar to those generated through the marketed multi-dose dry powder inhaler device.
If your doctor feels that you need a lower dose than is available from your Aerivio Spiromax, your doctor may prescribe an alternative inhaler containing the same active substances as your Aerivio Spiromax but with a lower dose of the corticosteroid.
Aerivio Spiromax is a medicine used for the regular treatment of adults with severe asthma and for the relief of symptoms of chronic obstructive pulmonary disease COPD, a long-term disease in which the airways and air sacs inside the lungs become damaged or blocked, leading to difficulty in breathing.
The Agency's Committee for Medicinal Products for Human Use(CHMP)concluded that Vylaer Spiromax 160/4.5 microgram and 320/9 microgram have been shown to have comparable quality and to be equivalent to the corresponding strengths of Symbicort Turbohaler.
Since Aerivio Spiromax is only available in one high strength(containing 50 micrograms of salmeterol and 500 micrograms of fluticasone propionate), should a lower strength become appropriate, patients should be switched to an alternative combination of salmeterol and fluticasone propionate containing a lower dose of fluticasone propionate.
Patients should be advised to have their rescue inhaler available at all times, either BiResp Spiromax(for asthma patients using BiResp Spiromax as maintenance and reliever therapy) or a separate rapid-acting bronchodilator for asthma patients using BiResp Spiromax as maintenance therapy only.
In asthma, Aerivio Spiromax can be used in patients whose disease is not adequately controlled despite treatment with a combination of a beta-2 agonist and a lower dose of inhaled corticosteroid, or those whose asthma is already controlled with a long-acting beta-2 agonist and a high-dose of inhaled corticosteroid.
In pharmacokinetic studies with and without a charcoal blockage, BiResp Spiromax was evaluated by comparing it with an alternative authorised fixed-dose combination inhaled product containing the same active substances, budesonide and formoterol and has been shown to be equivalent in both systemic exposure(safety) and pulmonary deposition efficacy.